+44 (0) 1223 755950
+1 832 327 7413
Suvratoxumab
REQUEST MORE INFO
Catalogue No: abx831418
Price:
US$435.00
(Size: 100 µg)
Reviews: 
(0 Publications and Reviews)
(0 Publications and Reviews)
Click on the image to see the image legend
Suvratoxumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting Staphylococcus aureus Alpha Toxin, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Suvratoxumab is under investigation in clinical trial NCT02296320 (Study of the Efficacy and Safety of MEDI4893).
Research Articles on Staphylococcus aureus Alpha Toxin
| Target | Staphylococcus aureus Alpha Toxin |
| Clonality | Monoclonal |
| Reactivity | Human |
| Expression | Recombinant |
| Tested Applications | ELISA, WB |
| Host | Human |
| Recommended dilutions | Optimal dilutions/concentrations should be determined by the end user. |
| Conjugation | Unconjugated |
| Isotype | IgG1 Kappa |
| Form | Liquid |
| Purity | > 95% |
| Purification | Purified from cell culture supernatants by Protein A/G chromatography. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Buffer | 0.01 M PBS. pH 7.4. |
| CAS Number | 1629620-18-3 |
| Concentration | Batch-dependent, typically between 0.5-2.0 mg/ml. |
| Availability | Shipped within 7-12 working days. |
| Note | This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use. |